AvidBiotics Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AvidBiotics Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10893
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AvidBiotics Corp (AvidBiotics) is a pharmaceutical company that develops non-antibody therapeutic proteins targeting cancer cells, virus-infected cells and pathogenic bacteria. The company develops a portfolio of therapeutic protein candidates and protein engineering platforms which include avidocin proteins, mica-body proteins and purocin proteins. Its avidocin proteins are used in the treatment of antibiotic-resistant bacterial infections and microbiota management diseases. AvidBiotics’ mica-body proteins are used in immune-oncology applications and treatment of viral infections. The company’s therapeutic proteins are designed to destroy target cells with surgical and laser precision. AvidBiotics is headquartered in South San Francisco, California, the US.

AvidBiotics Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AvidBiotics Raises USD0.9 Million in Venture Financing 11
AvidBiotics Raises Additional US$0.25 Million In Venture Financing 12
AvidBiotics Raises USD1.8 Million in Venture Financing 13
Partnerships 14
AvidBiotics Enters Into Research Agreement With Full Spectrum Genetics 14
Licensing Agreements 15
AvidBiotics Enters Into Co-Development Agreement With DuPont Nutrition To Develop Antibacterial Technology For Food Safety 15
AvidBiotics Corp – Key Competitors 16
AvidBiotics Corp – Key Employees 17
AvidBiotics Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
Nov 01, 2017: AvidBiotics Splits into Two Biotechnology Companies Each Developing its Distinct Technology Platform 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
AvidBiotics Corp, Pharmaceuticals & Healthcare, Key Facts 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AvidBiotics Raises USD0.9 Million in Venture Financing 11
AvidBiotics Raises Additional US$0.25 Million In Venture Financing 12
AvidBiotics Raises USD1.8 Million in Venture Financing 13
AvidBiotics Enters Into Research Agreement With Full Spectrum Genetics 14
AvidBiotics Enters Into Co-Development Agreement With DuPont Nutrition To Develop Antibacterial Technology For Food Safety 15
AvidBiotics Corp, Key Competitors 16
AvidBiotics Corp, Key Employees 17

List of Figures
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AvidBiotics Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fujitsu Limited:企業の戦略・SWOT・財務分析
    Fujitsu Limited - Strategy, SWOT and Corporate Finance Report Summary Fujitsu Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bank Of The Philippine Islands:企業の戦略・SWOT・財務分析
    Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Clinical Innovations LLC-医療機器分野:企業M&A・提携分析
    Summary Clinical Innovations LLC (Clinical Innovations), a subsidiary of Pritzker Group Company is a medical device company that offers healthcare products for women and infants. The company offers products such as safety heelsticks, traxi panniculus retractor, ROM plus membrane testing, tamponade s …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Deoleo, S.A.:企業の戦略・SWOT・財務情報
    Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report Summary Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cipla Ltd (CIPLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products for the treatment of various conditions such as cardiovascular and pediatric diseases, dermatological and cosmetologi …
  • Infratil Ltd (IFT):電力:M&Aディール及び事業提携情報
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • IOL Chemicals and Pharmaceuticals Ltd (IOLCP):企業の財務・戦略的SWOT分析
    IOL Chemicals and Pharmaceuticals Ltd (IOLCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Crowley Maritime Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Crowley Maritime Corp (Crowley Maritime) is a transportation and logistics company that offers marine solutions and services. Its service portfolio includes shipping and logistics, Alaska fuel sales and distribution, petroleum and chemical transportation, harbor ship assist and tanker escort …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Opsens Inc (OPS):医療機器:M&Aディール及び事業提携情報
    Summary Opsens Inc (Opsens), formerly DCB Capital Inc, is a provider of fiber optic sensing technology solutions. The company focuses on fractional flow reverse guidewire in interventional cardiology. It offers OptoWire, an optical-based pressure guidewire, which enhances the clinical outcome of pat …
  • Alcon Laboratories Inc:製品パイプライン分析
    Summary Alcon Laboratories Inc (Alcon), a division of Novartis AG, develops and manufactures devices in the field of Ophthalmology. The company’s portfolio encompasses contact lenses and surgical products. Alcon’s products are used for the treatment of various conditions such as cataracts, glaucoma, …
  • Hologic, Inc.:企業のM&A・事業提携・投資動向
    Hologic, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hologic, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Blaze Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Blaze Bioscience Inc (Blaze) is a biotechnology company that offers guided cancer therapy solutions. The company develops tumor paint products and optide-based guided cancer therapeutics. It provides cancer surgery by development of real-time, high-resolution view of cancer cell technologies …
  • Infineon Technologies AG (IFX):企業の財務・戦略的SWOT分析
    Infineon Technologies AG (IFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • WellCare Health Plans Inc (WCG)-製薬・医療分野:企業M&A・提携分析
    Summary WellCare Health Plans Inc (WellCare) is a managed care service provider which focuses on providing government-sponsored managed care services to families, children, seniors and individuals with complex medical needs. The company offers Medicaid health plans, Medicare Advantage (MA) coordinat …
  • Siemens AG (SIE):石油・ガス:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • Fairfax Financial Holdings Limited:企業の戦略・SWOT・財務情報
    Fairfax Financial Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Financial Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Cable & Wireless Communications Ltd:企業の戦略的SWOT分析
    Cable & Wireless Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆